These stocks trade at or under book value per share, implying that they cost less to buy than the value of the stuff they own. (Stocks include: GLW, CME)
Not to gloat, but a climb to $1,000 is looking mighty reasonable now.
Marshall Gordon, director of health care research for ClearBridge Advisors, names his favorite stocks including Centene and Onyx.
Market darling Westport Innovations has quickly become a spurned stock, but the reversal of fortune makes it a stock to watch.
Fighting for "entry-level" phone sales, the company is making the right move.
A month into the MLB season and baseball's beer drinking fans are already behind in the standings.
Wall Street is primed for a positive open after the iconic company sells more than 35 million iPhones in its latest quarter.
Water is the next commodity to face serious shortages.
Philip van Doorn
The TARP inspector General said on Wednesday that the most recent estimate was that the government's bank bailout efforts had cost $60 billion.
Here are today's top research calls.